ArticleClinical diabetes : a publication of the American Diabetes Association2023

Glucagon-Like Peptide 1 Receptor Agonists Have the Potential to Revolutionize the Attainment of Target A1C Levels in Type 2 Diabetes-So Why Is Their Uptake So Low?

Aaron King et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.